FIGURE 2.

Prevalence difference of having ≥1 diagnosed comorbidities associated with severe COVID-19 among people receiving HIV care in the United States, 2014–2019, the Medical Monitoring Project, N = 4473. A, Race/ethnicity, adjusted for age, reference group is White, non-Hispanic adults. B, Income at or below the poverty threshold, unadjusted, reference is income above the poverty threshold. C, Type of health insurance, unadjusted, reference is any private insurance. D, Ryan White HIV/AIDS Program funding of the usual place of care (health care facility), unadjusted, reference is no funding. Dashed red line is the meaningful threshold of increased prevalence. Dashed blue line is the meaningful threshold of decreased prevalence. Solid black line is the null threshold. ^aUnstable estimate (coefficient of variation is ≥0.3, absolute confidence interval is ≥30, and/or relative confidence interval is >130%). ^bPoverty guidelines as defined by the Department of Health and Human Services: https://aspe.hhs.gov/frequently-askedquestions-related-poverty-guidelines- and-poverty. ^cParticipants could select more than 1 response for health insurance or coverage for medications. ^dAny RWHAP funding (parts A, B, C, D, or F).